Sinovac Biotech
- All
- News
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
Australia Recognises Covaxin For Travel As It Eases Border Curbs
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
Chinese Sinovac Shot Seen As Highly Effective In Study
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
Brazil Authorises Emergency Use Of 2 Vaccines As Covid Enters Second Wave
Brazilian health regulator Anvisa on Sunday approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca, clearing the way for immunizations as the pandemic enters a deadly second wave.
-
China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism
Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks.
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
China's Sinovac Secures $515 Million To Boost Covid Vaccine Production
China's Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month.
-
China Covid Vaccine Induces Quick Immune Response Within 4 Weeks: Study
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
-
Sinovac's Covid Vaccine Candidate Approved For Emergency Use In China: Report
Sinovac Biotech coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
Australia Recognises Covaxin For Travel As It Eases Border Curbs
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
Chinese Sinovac Shot Seen As Highly Effective In Study
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
Brazil Authorises Emergency Use Of 2 Vaccines As Covid Enters Second Wave
Brazilian health regulator Anvisa on Sunday approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca, clearing the way for immunizations as the pandemic enters a deadly second wave.
-
China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism
Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks.
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
China's Sinovac Secures $515 Million To Boost Covid Vaccine Production
China's Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month.
-
China Covid Vaccine Induces Quick Immune Response Within 4 Weeks: Study
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
-
Sinovac's Covid Vaccine Candidate Approved For Emergency Use In China: Report
Sinovac Biotech coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
